Document Detail

Risk factors and growth factors in ROP.
MedLine Citation:
PMID:  19828269     Owner:  NLM     Status:  MEDLINE    
Retinopathy of prematurity (ROP) is a multifactorial disease which incidence is increasing with increasing survival of very preterm infants. Pathogenic pathway is characterised by abnormal retinal vascular development modulated by vascular growth factors: low IGF-1 in the first phase and high VEGF in the second phase. Many causal factors are able to influence retinal vascularization: gestational age, birth weight, oxygen administration, perinatal bacterial or fungal infections, and blood transfusions. All risk factors, both oxygen and not-oxygen-regulated, have been studied considering the whole period from hospital birth to the hospital discharge, but it is possible that postnatal risk factors may be determinant in a time-dependent way. Analysis of factors involved in the pathogenesis of ROP suggests that their action begins long before anatomical clinical features become appreciable and this is strengthened by the essential role of risk factors from the first two to four weeks of life, thus preventive strategies in very preterm infants should be carried out since birth.
C Romagnoli
Related Documents :
24401869 - Interventions using electronic medical records improves follow up of infants born to he...
21510569 - One year experience of neonatal mortality and morbidity in a state level neonatal inten...
25125229 - Haemodialysing babies weighing <8 kg with the newcastle infant dialysis and ultrafiltr...
20660549 - Retinopathy of prematurity in 7 neonatal units in rio de janeiro: screening criteria an...
1553319 - Retinopathy of prematurity: risk factors in a prospective population-based study.
12930159 - Retinopathy of prematurity: molecular pathology and therapeutic strategies.
22613269 - Comparison of oral and intravenous ibuprofen for medical closure of patent ductus arter...
8421739 - Cervical trachea: dynamics in response to herniation of the normal thymus.
23445639 - A pilot cohort analytic study of family integrated care in a canadian neonatal intensiv...
Publication Detail:
Type:  Journal Article     Date:  2009-10-14
Journal Detail:
Title:  Early human development     Volume:  85     ISSN:  1872-6232     ISO Abbreviation:  Early Hum. Dev.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-11-02     Completed Date:  2010-02-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7708381     Medline TA:  Early Hum Dev     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  S79-82     Citation Subset:  IM    
Division of Neonatology, Catholic University of Rome, Largo A. Gemelli, 8 00168, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Birth Weight
Blood Transfusion / adverse effects
Gestational Age
Infant, Newborn
Insulin-Like Growth Factor I / metabolism
Oxygen / adverse effects,  therapeutic use
Retinopathy of Prematurity / epidemiology*,  pathology,  prevention & control
Risk Factors
Time Factors
Vascular Endothelial Growth Factor A / metabolism
Reg. No./Substance:
0/VEGFA protein, human; 0/Vascular Endothelial Growth Factor A; 67763-96-6/Insulin-Like Growth Factor I; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biology and intracellular pathogenesis of high or low virulent Chlamydophila psittaci strains in chi...
Next Document:  Comparison of the strengths and difficulties questionnaire (SDQ) scores between children with high-f...